John Luther Lentz, M.D., and J. Luke Lentz, M.D., PA  


    Board of Medicine

    Notice is hereby given that the Board of Medicine has received a Petition for Declaratory Statement filed on behalf of John Luther Lentz, M.D., and J. Luke Lentz, M.D., PA, on November 26, 2012. The Petitioner seeks the Board’s interpretation of Section 458.3265, F.S., and seeks the Board’s determination that the Petitioner’s use of suboxone for the purpose of reducing opioid dependence in patients of the Petitioner does not qualify the Petitioners as a “pain management clinic” under the provisions of Section 458.3265, F.S. The Board will consider this petition at its meeting currently scheduled for February 1-2, 2013. Copies of the petition may be obtained by writing Allison M. Dudley, J.D., Executive Director, Board of Medicine, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253.

Document Information